Baxter International | BAX - Ativos





Ativos Alterar Data
Abbott USD 110.43B 23.72B 2026-03
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 883.16M 1.64M 2026-03
AtriCure USD 643.99M 10.19M 2026-03
Avanos Medical USD 1.05B 23.6M 2026-03
Baxter International USD 19.85B 209M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Cooper Companies USD 12.48B 58.1M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Fresenius EUR 41.4B 1.07B 2025-12
Globus Medical USD 5.44B 136.79M 2026-03
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
ICU Medical USD 4.01B 36.74M 2026-03
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.72B 33.36M 2026-03
Quest Diagnostics USD 16.67B 448M 2026-03
Smith & Nephew USD 10.69B 150M 2025-12
Stryker USD 46.29B 1.55B 2026-03
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Terumo JPY 2.31T 55.3B 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03